Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.
Status:
Completed
Trial end date:
2019-12-11
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of Rheosorbilact®, solution for infusion
("Yuria-Pharm" LLC), in comparison with Ringer's Lactate, solution for infusion, in a complex
therapy of sepsis. Half of participants will receive Rheosorbilact® in complex therapy, while
the other half will receive Ringer's Lactate in complex therapy.